Advitech
Calgary
About Advitech
Advitech is a life science and technology company with the mission to discover and commercialize patented, scientifically supported natural health products. Effective and safe, these products target immune system disorders, such as psoriasis and inflammatory bowel disease. Advitech produces Dermylex (R) for the treatment of mild to moderate psoriasis. Advitech has developed a research program to develop new applications in the field of wound healing. This development program stems from the two technological platforms XP-828L and IM.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Last round: Series Unknown (Jul 2010)
- Website: advitech.com
- Phone: (403) 770-9654
Industries & Categories
Biotechnology, Developer Platform, Nutraceutical
Social Profiles
Canonical: https://fsome.com/organization/advitech-2853625 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.